BioAtla Investor Presentation Deck
Leadership Team
bicatla
Jay Short, Ph.D.
Chairman, CEO and Cofounder
STRATAGENE
DIVERSA
HARNESSING THE POWER OF ENZYMES
SYNTHETIC GENOMICS
life
Cathy Chang, Ph.D.
Sr. VP, Research & Development
DIVERSA
HARNESSING THE POWER OF ENZYMES
technologies
STRATAGENE
Richard Waldron, M.B.A.
Chief Financial Officer
INTREXON GeneMedicine, Inc. COWEN
AND COMPANY
William Boyle, Ph.D.
Sr. Research Fellow
Anaptys Bio AMGEN salk
Where cures begin.
Eric Sievers, M.D.
Chief Medical Officer
OSeattleGenetics ZYMOGENETICS
A Bristol-Myers Squibb Company
Monica Sullivan
Sr. VP, Intellectual Property & Contracts
STRATAGENE
FRED HUTCH
CURES START HERE"
DIVERSA
BARNESSING THE POWER OF ENZYMES
CapalP
Celgene
Sheri Lydick
Chief Commercial Officer
Bristol Myers Squibb™ ALTANA
Susie Melody
Sr. VP, Human Resources
senomyx
Biogen.
BCG
BioAtla| Overview
4View entire presentation